Search Results
Jens Juul Holst at ARDD2022: Overview of incretin based therapies of metabolic disease
INCRETIN THERAPY: PRESENT AND FUTURE
Hybrid Symposium June 2021 | Sten Madsbad & Jens Juul Holst
Gordon J Lithgow for the ARDD2022: Chemical interventions in aging promoting Healthspan
RVH Medical Grand Rounds: Incretin Based Therapy in the Management of Diabetes
From Gut Hormones to the Obesity Crisis - Jens J. Holst, MD
Incretins | Pharmacology
APDF: Benefits of Incretin based therapies - Current status - Dr Jabbar Puthiveetil
Stephen Helliwell at ARDD2022: Age Better, Live longer, with Rejuveron Life Sciences
Nir Barzilai at ARDD2022: The genetics of exceptional longevity
From the monster's mouth
Dan Drucker & Michael Nauck take us on a journey through the development of GLP-1 receptor agonists
